We further validated and performed immunohistochemical staining of TNBC tissues derived from 6 patient derived xenograft (PDX) models using CD74 antibody and found that CD74 is highly expressed in an aggressive form of breast cancer, TNBC (Figure 3B). Here, CD74 is linked to breast carcinoma.